Order Article Reprints

Garousi J, Ding H, von Witting E, Xu T, Vorobyeva A, Oroujeni M, Orlova A, Hober S, Gräslund T, Tolmachev V. Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics. 2021; 13(11):1847. https://doi.org/10.3390/pharmaceutics13111847

Garousi, Javad, Haozhong Ding, Emma von Witting, Tianqi Xu, Anzhelika Vorobyeva, Maryam Oroujeni, Anna Orlova, Sophia Hober, Torbjörn Gräslund, and Vladimir Tolmachev. 2021. "Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein" Pharmaceutics 13, no. 11: 1847. https://doi.org/10.3390/pharmaceutics13111847

Garousi, J., Ding, H., von Witting, E., Xu, T., Vorobyeva, A., Oroujeni, M., Orlova, A., Hober, S., Gräslund, T., & Tolmachev, V. (2021). Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity Protein. Pharmaceutics, 13(11), 1847. https://doi.org/10.3390/pharmaceutics13111847